If you're wondering what actually goes on medically during inpatient detox, medication-assisted treatment plays a central role for a large share of people working through withdrawal, and it's often built into personalized Newfane rehab programs alongside broader drug detox services. Yet it remains one of the most misunderstood pieces of the process, frequently mistaken for simply swapping one substance for another, or brushed off by people who assume recovery means quitting everything cold turkey from day one.
Here's a straightforward look at what MAT actually involves, how it functions within an inpatient setting, and what a person can realistically expect once it becomes part of their clinical plan.
What Medication-Assisted Treatment Is and What It Is Not
Medication-assisted treatment (MAT) is the use of FDA-approved medications, alongside counseling and clinical support, to treat substance use disorder. In the context of inpatient detox, those medications are used primarily to manage withdrawal symptoms, reduce the physical severity of coming off a substance, and lower the risk of dangerous medical complications.
What MAT is not: a way to stay intoxicated, a substitute addiction, or evidence that someone isn't serious about recovery. That characterization comes up frequently, especially in older treatment frameworks, and it isn't supported by what the research actually shows. The medications used in MAT work on brain chemistry differently than the substances they're treating. They don't produce the euphoric effect that drives compulsive use. They stabilize. The clinical goal is to get a person through acute withdrawal safely, so the real work of treatment, counseling, behavioral therapy, psychiatric support, can actually begin.
Why MAT Is Now the Standard of Care for Withdrawal Management
Opioid and alcohol withdrawal are not just uncomfortable. Without medical management, both can become medically dangerous. Alcohol withdrawal in someone with a history of heavy daily drinking can cause seizures and, in the most severe cases, a condition called delirium tremens that carries real medical risk without proper intervention. Opioid withdrawal on its own is rarely fatal, but the physical severity makes relapse almost certain without support, and the risk of fatal overdose increases sharply after even a brief period of abstinence because opioid tolerance drops rapidly.
MAT exists because managing these withdrawal processes without clinical tools is both less safe and less effective than managing them with them. The shift in the addiction treatment field over the past two decades has been toward treating substance use disorder as a medical condition, which means treating withdrawal medically. OASAS-licensed inpatient detox programs in New York are built around this standard of care.
The Medications We Use in Inpatient Detox
Different substances and different clinical presentations call for different medications. Our medical team makes those determinations based on the individual assessment completed at admission, not a one-size-fits-all protocol applied to everyone who walks in.
For opioid dependence, the primary medications we use are Suboxone and Buprenorphine. Buprenorphine is a partial opioid agonist, which means it activates the same receptors as opioids but only partially. That's enough to significantly reduce withdrawal symptoms and cravings without producing the full effect of opioids. The naloxone component in Suboxone adds an additional layer of protection against misuse. For clients where a long-acting injectable is clinically appropriate, Sublocade provides extended-release buprenorphine in a once-monthly dose.
Vivitrol (naltrexone) works differently. It's an opioid antagonist, meaning it blocks opioid receptors entirely, removing the reward from use. Because starting Vivitrol requires the person to be fully clear of opioids first, it's typically introduced after the acute detox phase rather than during it. It's also used for alcohol use disorder.
For alcohol and benzodiazepine withdrawal, the approach is a medically supervised tapering protocol rather than MAT in the same sense. A physician manages a gradual dose reduction to bring the body off the substance at a pace that prevents dangerous complications like seizures, while keeping withdrawal symptoms manageable throughout.
How MAT Works Inside a 24-Hour Clinical Setting
The inpatient setting is what makes MAT meaningful rather than just a prescription. In an outpatient MAT clinic, a person picks up their medication and takes it at home. There's no clinical monitoring between doses. There's no one to call if withdrawal symptoms spike unexpectedly.
In our inpatient detox program, nursing staff are present around the clock. Vitals are checked on a regular schedule. Medications are administered and monitored directly by the clinical team, not self-managed. If a client's condition changes, the medical team responds immediately, not at the next scheduled appointment.
That level of supervision also allows for dosing flexibility that outpatient MAT can't offer. If a starting dose isn't sufficient to manage symptoms, it gets adjusted the same day. Psychiatric evaluation within the first 24 hours of admission is also standard in our program, and what comes out of that evaluation often directly informs the MAT plan. Co-occurring depression, anxiety, or PTSD affects which medications are appropriate and how the clinical team shapes the rest of the treatment plan.
What to Expect When MAT Is Part of Your Detox Plan
The process starts at admission. A nurse takes vitals, reviews medical history, collects a urine sample, and records current medications. That information goes to the medical team, who builds a medication plan based on what the assessment shows.
For someone entering opioid detox, buprenorphine induction typically begins when early withdrawal symptoms are present. For short-acting opioids like heroin, that's generally within 12 to 24 hours of the last use. Starting before withdrawal symptoms appear can trigger precipitated withdrawal, a more sudden and severe onset of symptoms, so timing the first dose is a clinical decision, not an arbitrary one.
The days that follow involve ongoing monitoring, medication adjustments as needed, and the beginning of therapeutic programming. Withdrawal symptoms are not eliminated entirely in most cases, but they are significantly reduced. The goal is to keep the person stable enough to participate in treatment and bring them through the acute phase without medical complications.
Once detox is complete, the transition into our 28-day residential rehabilitation program happens directly, with the same clinical team. There's no transfer, no break in care, and no starting over with a new facility. For detailed information on what the first 24 hours look like, our admissions page covers the process clearly.
Frequently Asked Questions
Is MAT the same as trading one addiction for another?
No. This is a persistent misconception. MAT medications like buprenorphine are dosed specifically to manage withdrawal symptoms and reduce cravings. They don't produce the effect that drives compulsive use. Using MAT as part of treatment is a clinical approach to a medical condition, not a substitute dependency.
How long does MAT continue after detox?
That depends on the individual. For some, MAT continues through the residential program and into outpatient aftercare. For others, it's primarily a tool for managing the acute detox phase. Our medical team reviews MAT needs throughout the stay and makes adjustments based on clinical progress.
What medications does Niagara Recovery use in detox?
We use Suboxone, Buprenorphine, Sublocade, and Vivitrol for opioid and alcohol use disorder. Our medical team determines which medication is appropriate based on the individual assessment at admission.
Is inpatient MAT covered by Medicaid in New York?
Most Medicaid plans in New York cover inpatient detox at OASAS-licensed facilities, which includes MAT as part of the clinical program. We have a staff member dedicated to handling insurance verification. Call us to confirm what your specific plan covers.
Is MAT available for alcohol use disorder, or only for opioid dependence?
Vivitrol (naltrexone) is used for both opioid and alcohol use disorder. For alcohol withdrawal specifically, a medically supervised tapering protocol is the primary approach. Our medical team determines the right combination based on each person's clinical picture.
Ready to Talk About Detox
If you or someone you care about is facing opioid or alcohol dependence, medically supervised detox with MAT support is available at our facility. Same-day admissions are possible, and we handle insurance verification before admission. Reach out to us to begin the journey toward recovery.
Facility Address: 2600 William St, Newfane, NY 14108
- Intake Phone: (716) 203-8000
- Facility Phone: (716) 265-3700
Email: admissions@niagararecovery.com
Office Hours: Monday–Sunday: 24 hours
Related Topics:
- Why Choose a Specialized Drug and Alcohol Rehab Center in Newfane
- How to Recognize Signs of Substance Abuse Before It Requires Rehab
